Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Elliott

Showing results (211-220 of 756) with videos related to

Pageof 76
Sort By:
Journal of Clinical Microbiology|October 1, 1982
Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiationL H Elliott, J B McCormick, K M Johnson
Behaviour Research and Therapy|January 1, 1980
Suppression and substitution in the treatment of nailbitingA M Davidson, D R Denney, C H Elliott
Ophthalmology|March 1, 1986
Visual impairment following radial keratotomy. A cluster of casesD M O'Day, S S Feman, J H Elliott
The Biochemical Journal|November 15, 1978
Proteinase-sensitive release of enzymes from pancreatic microsomal fractionP D Pearce, B K May, W H Elliott
Journal of Neurogenetics|January 14, 2010
Postmating change in physiology of male Drosophila mediated by serotonin (5-HT)Katie Norville, Sean T Sweeney, Christopher J H Elliott
Proceedings. Biological Sciences|June 30, 2017
Fear creates an Allee effect: experimental evidence from seasonal populationsKyle H Elliott, Gustavo S Betini, D Ryan Norris
The American Review of Respiratory Disease|April 1, 1975
Suppression of lymphocyte function by products derived from cigarette smokeT L Roszman, L H Elliott, A S Rogers
Brain Research Bulletin|May 3, 2005
Circadian control during the day and night: Role of neuropeptide Y Y5 receptors in the suprachiasmatic nucleusKaren L Gamble, J Christopher Ehlen, H Elliott Albers
Cancer|October 1, 1982
Immunobiology of primary intracranial tumors. VI. Suppressor cell function and lectin-binding lymphocyte subpopulations in patients with cerebral tumorsT L Roszman, W H Brooks, L H Elliott
The Journal of Clinical Investigation|July 1, 1990
Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptorsL H Elliott, W H Brooks, T L Roszman
Pageof 76

Showing results (211-220 of 756) with videos related to

Sort By:
Pageof 76
Journal of Clinical Microbiology|October 1, 1982
Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiationL H Elliott, J B McCormick, K M Johnson
Behaviour Research and Therapy|January 1, 1980
Suppression and substitution in the treatment of nailbitingA M Davidson, D R Denney, C H Elliott
Ophthalmology|March 1, 1986
Visual impairment following radial keratotomy. A cluster of casesD M O'Day, S S Feman, J H Elliott
The Biochemical Journal|November 15, 1978
Proteinase-sensitive release of enzymes from pancreatic microsomal fractionP D Pearce, B K May, W H Elliott
Journal of Neurogenetics|January 14, 2010
Postmating change in physiology of male Drosophila mediated by serotonin (5-HT)Katie Norville, Sean T Sweeney, Christopher J H Elliott
Proceedings. Biological Sciences|June 30, 2017
Fear creates an Allee effect: experimental evidence from seasonal populationsKyle H Elliott, Gustavo S Betini, D Ryan Norris
The American Review of Respiratory Disease|April 1, 1975
Suppression of lymphocyte function by products derived from cigarette smokeT L Roszman, L H Elliott, A S Rogers
Brain Research Bulletin|May 3, 2005
Circadian control during the day and night: Role of neuropeptide Y Y5 receptors in the suprachiasmatic nucleusKaren L Gamble, J Christopher Ehlen, H Elliott Albers
Cancer|October 1, 1982
Immunobiology of primary intracranial tumors. VI. Suppressor cell function and lectin-binding lymphocyte subpopulations in patients with cerebral tumorsT L Roszman, W H Brooks, L H Elliott
The Journal of Clinical Investigation|July 1, 1990
Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptorsL H Elliott, W H Brooks, T L Roszman
Pageof 76